| Application no. and date | 04768469.1 (espacenet) (Federated) (European Patent Register), 20040913 | | Patent/reg. no. and date | DK/EP 1667991, 20080514 | | Publication date | 20060614 | | Priority no. and date | GB 0321620, 20030916, GB 0406163, 20040319 | | EP pub. no. and date |
EP 1667991 20060614 | | Effective date | | | Applicant/owner | Astrazeneca AB, S-151 85 Sodertalje, SE | | Applicant ref. no. | AST 101211-1X | | Inventor | HENNEQUIN, Laurent Francois Andre, AstraZeneca Pharma,
Z.I. la Pompelle,
BP 1050
51689 Reims, FR,
HALSALL, Christopher Thomas, AstraZeneca R & D Alderley,
Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61P 35/00 (2006.01) , C07D 401/12 (2006.01) , C07D 401/14 (2006.01) , C07D 405/14 (2006.01) | | Title | Quinazolinderivater som tyrosinkinaseinhibitorer | | Int. application no. | GB2004003923 | | Int. publication no. | WO2005026150 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
